Vol. I · No. 1 · May 2026
Lawsuit Intelligencer
Editorial analysis of mass torts, product liability, toxic exposure litigation, and the business of plaintiff-side law in the age of AI.
Vol. I · No. 1 · May 2026
Editorial analysis of mass torts, product liability, toxic exposure litigation, and the business of plaintiff-side law in the age of AI.
Lawsuit Intelligencer covers the lawsuits, regulations, referral systems, legal marketing practices, and technologies reshaping modern litigation — the questions that don't fit in consumer legal media or law firm marketing.
Featured Analysis
The 2024 EPA drinking water standards looked like a foundation for the next wave of PFAS litigation. EPA's 2025–2026 rollback collapsed that assumption. What changes for plaintiff lawyers when the federal anchor moves and the state floors don't.
Read the analysis →Recent
The Eleventh Circuit's 2025 vacatur of the one-to-one consent rule is being misread as a regulatory all-clear. The actual pressure has just shifted to TCPA class actions and state bar enforcement.
What this publication is, what it isn't, and why it exists.
What We Cover
PFAS, AFFF, talc, pharmaceutical and medical device litigation, MDL practice, and the doctrines moving through them.
Intake, referral economics, lead generation, legal marketing, AI in legal practice, firm consolidation, and the regulatory environment around all of it.
Federal and state agency action — EPA, FDA, FCC, state AGs, state bars — analyzed for what it means in court, not what the press release said.